Surrozen Inc

Biotech Stocks Healthcare Stocks

$22.80

+1.55 (+7.29%)

As of Feb 8, 2:05 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 88%

Hold 1 13%

Sell 0 0%

Price Target

Analyst Price Target -65.2% upside

Low Target $5.53

Average Target $7.94

High Target $9.87

Current Price $22.80

Current
$22.80

Target
$7.94

$5.53 $7.94 avg $9.87

Scenario Analysis

Bear Case

$5.53

-75.7%

Low target

Base Case

$7.94

-65.2%

Avg target

Bull Case

$9.87

+-56.7%

High target

Risk/Reward

0.7x

Unfavorable

Price in Context

52-Week High

$6.84

233.3% from high

52-Week Low

$3.13

+628.4% from low

Target vs 52W High

$7.94

+16.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%